Guillermo Delmonte - RAMM Pharma Interim COO
Insider
Guillermo Delmonte is Interim COO of RAMM Pharma Corp
| Phone | 416 848 7744 |
| Web | https://www.rammpharma.com |
RAMM Pharma Management Efficiency
The company has return on total asset (ROA) of (0.0789) % which means that it has lost $0.0789 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1238) %, meaning that it generated substantial loss on money invested by shareholders. RAMM Pharma's management efficiency ratios could be used to measure how well RAMM Pharma manages its routine affairs as well as how well it operates its assets and liabilities.RAMM Pharma Corp has accumulated 8.69 K in total debt. RAMM Pharma Corp has a current ratio of 9.0, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist RAMM Pharma until it has trouble settling it off, either with new capital or with free cash flow. So, RAMM Pharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like RAMM Pharma Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for RAMM to invest in growth at high rates of return. When we think about RAMM Pharma's use of debt, we should always consider it together with cash and equity.
RAMM Pharma Corp. engages in the research and development, production, and sale of cannabinoid pharmaceutical formulations, pharmaceuticals, cosmetics, nutraceutical products, and resale of medical supplies products in Canada and internationally. RAMM Pharma Corp. was incorporated in 1987 and is based in Toronto, Canada. Ramm Pharma is traded on OTC Exchange in the United States. RAMM Pharma Corp [RAMMF] is a Pink Sheet which is traded between brokers as part of OTC trading. Management Performance
| Return On Equity | -0.12 | |||
| Return On Asset | -0.0789 |
RAMM Pharma Corp Leadership Team
Elected by the shareholders, the RAMM Pharma's board of directors comprises two types of representatives: RAMM Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of RAMM. The board's role is to monitor RAMM Pharma's management team and ensure that shareholders' interests are well served. RAMM Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, RAMM Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jackie Burnett, CEO Pres | ||
| Guillermo Delmonte, Interim COO |
RAMM Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is RAMM Pharma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.12 | |||
| Return On Asset | -0.0789 | |||
| Profit Margin | (1.76) % | |||
| Operating Margin | (1.89) % | |||
| Current Valuation | 1.85 M | |||
| Shares Outstanding | 122.4 M | |||
| Shares Owned By Insiders | 34.88 % | |||
| Shares Owned By Institutions | 0.89 % | |||
| Price To Book | 0.18 X | |||
| Price To Sales | 4.04 X |
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Consideration for investing in RAMM Pink Sheet
If you are still planning to invest in RAMM Pharma Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RAMM Pharma's history and understand the potential risks before investing.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |